Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Multiple System Atrophy Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Multiple System Atrophy Therapeuticsmarket, defines the market attractiveness level of Multiple System Atrophy Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Multiple System Atrophy Therapeutics industry, describes the types of Multiple System Atrophy Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Multiple System Atrophy Therapeutics market and the development prospects and opportunities of Multiple System Atrophy Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Multiple System Atrophy Therapeutics market in Chapter 13.
By Player:
AFFiRiS AG
Corestem Inc
MitoDys Therapeutics Ltd
Prana Biotechnology Ltd
Neuropore Therapies Inc
Modag GmbH
AstraZeneca Plc
By Type:
Anle-138b
AZD-3241
CS-10BR05
NPT-20011
PBT-434
PD-01
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Multiple System Atrophy Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Multiple System Atrophy Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Multiple System Atrophy Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Multiple System Atrophy Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Multiple System Atrophy Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.2 United States Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.3 Europe Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.4 China Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.5 Japan Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.6 India Multiple System Atrophy Therapeutics Consumption (2017-2022)
-
7.7 South Korea Multiple System Atrophy Therapeutics Consumption (2017-2022)
8 Region and Country-wise Multiple System Atrophy Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Multiple System Atrophy Therapeutics Consumption Forecast (2022-2028)
9 Global Multiple System Atrophy Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Multiple System Atrophy Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anle-138b Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AZD-3241 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CS-10BR05 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global NPT-20011 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global PBT-434 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global PD-01 Consumption and Growth Rate (2017-2022)
-
9.2 Global Multiple System Atrophy Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Multiple System Atrophy Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anle-138b Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AZD-3241 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CS-10BR05 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global NPT-20011 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global PBT-434 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global PD-01 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Multiple System Atrophy Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Multiple System Atrophy Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Multiple System Atrophy Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Multiple System Atrophy Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Multiple System Atrophy Therapeutics Market Competitive Analysis
-
14.1 AFFiRiS AG
-
14.1.1 AFFiRiS AG Company Details
-
14.1.2 AFFiRiS AG Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AFFiRiS AG Multiple System Atrophy Therapeutics Product and Service
-
14.2 Corestem Inc
-
14.2.1 Corestem Inc Company Details
-
14.2.2 Corestem Inc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Corestem Inc Multiple System Atrophy Therapeutics Product and Service
-
14.3 MitoDys Therapeutics Ltd
-
14.3.1 MitoDys Therapeutics Ltd Company Details
-
14.3.2 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Product and Service
-
14.4 Prana Biotechnology Ltd
-
14.4.1 Prana Biotechnology Ltd Company Details
-
14.4.2 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Product and Service
-
14.5 Neuropore Therapies Inc
-
14.5.1 Neuropore Therapies Inc Company Details
-
14.5.2 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Product and Service
-
14.6 Modag GmbH
-
14.6.1 Modag GmbH Company Details
-
14.6.2 Modag GmbH Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Modag GmbH Multiple System Atrophy Therapeutics Product and Service
-
14.7 AstraZeneca Plc
-
14.7.1 AstraZeneca Plc Company Details
-
14.7.2 AstraZeneca Plc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Plc Multiple System Atrophy Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Multiple System Atrophy Therapeutics
-
Figure Multiple System Atrophy Therapeutics Picture
-
Table Global Multiple System Atrophy Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple System Atrophy Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple System Atrophy Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Multiple System Atrophy Therapeutics Consumption by Country (2017-2022)
-
Figure United States Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Multiple System Atrophy Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple System Atrophy Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Multiple System Atrophy Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anle-138b Consumption and Growth Rate (2017-2022)
-
Figure Global AZD-3241 Consumption and Growth Rate (2017-2022)
-
Figure Global CS-10BR05 Consumption and Growth Rate (2017-2022)
-
Figure Global NPT-20011 Consumption and Growth Rate (2017-2022)
-
Figure Global PBT-434 Consumption and Growth Rate (2017-2022)
-
Figure Global PD-01 Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Anle-138b Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AZD-3241 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CS-10BR05 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NPT-20011 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PBT-434 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PD-01 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Multiple System Atrophy Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Multiple System Atrophy Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table AFFiRiS AG (Foundation Year, Company Profile and etc.)
-
Table AFFiRiS AG Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AFFiRiS AG Multiple System Atrophy Therapeutics Product and Service
-
Table Corestem Inc (Foundation Year, Company Profile and etc.)
-
Table Corestem Inc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corestem Inc Multiple System Atrophy Therapeutics Product and Service
-
Table MitoDys Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Product and Service
-
Table Prana Biotechnology Ltd (Foundation Year, Company Profile and etc.)
-
Table Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Product and Service
-
Table Neuropore Therapies Inc (Foundation Year, Company Profile and etc.)
-
Table Neuropore Therapies Inc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuropore Therapies Inc Multiple System Atrophy Therapeutics Product and Service
-
Table Modag GmbH (Foundation Year, Company Profile and etc.)
-
Table Modag GmbH Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Modag GmbH Multiple System Atrophy Therapeutics Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Multiple System Atrophy Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Multiple System Atrophy Therapeutics Product and Service
-
